ObvioHealth’s proprietary app & platform make virtual clinical trials safer, easier, faster and better at generating the data needed to support your health innovation.
See HowFaster Recruitment
Up to*
ePro Compliance
Retention Rate
We launched the one of the first patient-centric apps, making it easy for people to participate in digital clinical trials from the comfort of their homes. Our platform and app are backed by a team of clinical experts who offer support to participants every step of the way. This combination of tech and team boosts engagement. And when participants are engaged, you get better data.
Our Patient-centric features include:
Request a Demo
Read more about our remote monitoring capabilities
ObvioHealth has conducted 42 studies in 28 countries with more than 25,000 participants. Click through the therapeutic areas below to see some of our case studies.
ObvioHealth studies are run on our purpose-built platform by our own in-house virtual team. This allows us to work seamlessly from protocol design all the way through to analysis and reporting.
ObvioHealth is pioneering new ways to collect clinical trial data. Our innovative platform seamlessly integrates with clinical-grade devices, our novel instruments reduce ePRO subjectivity, and our virtual study coordinators carefully monitor and support patients. The result? Faster, safer and more accurate trials.
Traditionally, electronic patient reported outcomes (ePRO) were collected on provisioned devices provided by clinical sites. Patient retention in clinical trials depended largely on the sites’ ability to engage patients during visits. The arrival of “bring your own device” (BYOD) models has enabled patients to complete ePRO in clinical trials using their own smartphones.
Childhood pneumonia and other respiratory illnesses are a lingering plague in many developing nations. Though incidences of pneumonia have decreased overall, the disease is the leading infectious cause of death in children globally, affecting one in six childhood deaths. Pneumonia claimed the lives of 921,000 children younger than 5 in 2015, according to the most recent data published in The Lancet Global Health.
ObvioHealth, a leading global Virtual Research Organization (VRO) pioneering end-to-end decentralized clinical trial solutions, announces the development of two novel digital instruments to increase accuracy and reduce patient/caregiver burden in pediatric clinical trials.
Cohorts of young children and their caregivers are infamously challenging. Pediatric study teams struggle to meet the needs of everyone involved—from wiggly toddlers to harried parents—to bring safe, effective products to market.
Request a Demo